Biological assessment of Coccinia grandis leaf and Lupeol against β-lactam resistant Klebsiella pneumoniae through integrated in-silico and in-vitro studies

biological-assessment-of-coccinia-grandis-leaf-and-lupeol-against-β-lactam-resistant-klebsiella-pneumoniae-through-integrated-in-silico-and-in-vitro-studies
Biological assessment of Coccinia grandis leaf and Lupeol against β-lactam resistant Klebsiella pneumoniae through integrated in-silico and in-vitro studies

References

  1. Khumalo, G. P., Van Wyk, B. E., Feng, Y. & Cock, I. E. Toxicity and phytochemical properties of southern African medicinal plants used traditionally to treat pain and inflammatory ailments. South. Afr. J. Bot. 160, 102–122. https://doi.org/10.1016/j.sajb.2023.07.005 (2023).

    Google Scholar 

  2. Jabborova, D., Davranov, K. & Egamberdieva, D. Antibacterial, antifungal, and antiviral properties of medical plants. Medically Important Plant Biomes: Sourc Sec Metabol. pp51-65. (2019). https://doi.org/10.1007/978-981-13-9566-6_3

  3. Tariq, L., Bhat, B. A., Hamdani, S. S. & Mir, R. A. Phytochemistry, pharmacology and toxicity of medicinal plants. Medicinal and Aromatic Plants: Healthcare Industr App. pp217-40 (2021). https://doi.org/10.1007/978-3-030-58975-2_8

  4. Namchaiw, P. et al. The leaf extract of Coccinia grandis (L.) Voigt accelerated in vitro wound healing by reducing oxidative stress injury. Oxidat Med Cell Long. 3963510. (2021). (1) https://doi.org/10.1155/2021/3963510 (2021).

  5. Kondhare, D. & Lade, H. Phytochemical profile, aldose reductase inhibitory, and antioxidant activities of Indian traditional medicinal Coccinia grandis (L.) fruit extract. 3 Biotech. 7 (6), 378. https://doi.org/10.1007/s13205-017-1013-1 (2017).

    Google Scholar 

  6. Sakharkar, P. & Chauhan, B. Antibacterial, antioxidant and cell proliferative properties of Coccinia grandis fruits. Avicenna J. phytomed. 7 (4), 295 (2017).

    Google Scholar 

  7. Pratoomsoot, C., Wongkattiya, N. & Sanguansermsri, D. Synergistic antimicrobial and antioxidant properties of Coccinia grandis (L.) Voigt, Clerodendrum inerme (L.) Gaertn. and Acanthus ebracteatus Vahl. extracts and their potential as a treatment for xerosis cutis. Complement. Med. Res. 27 (6), 410–420. https://doi.org/10.1159/000507606 (2020).

    Google Scholar 

  8. Dubey, D. et al. Evaluation of the antibacterial activity of Coccinia grandis, against bacteria isolated from chronic suppurative otitis media infection. J. appl. biol. 11, 139–145. https://doi.org/10.7324/JABB.2023.110119 (2022).

    Google Scholar 

  9. Lin, Y. Y. et al. Head and neck cancers manifested as deep neck infection. Eur. Arch. Oto-Rhino-Laryngol. 269, 585–590. https://doi.org/10.1007/s00405-011-1622-y (2012).

    Google Scholar 

  10. Kauffmann, P., Cordesmeyer, R., Tröltzsch, M., Sömmer, C. & Laskawi, R. Deep neck infections: A single-center analysis of 63 cases. Med. oral patologia oral y Cir. bucal. 22 (5), e536. https://doi.org/10.4317/medoral.21799 (2017).

    Google Scholar 

  11. Aurilio, C. et al. Mechanisms of action of carbapenem resistance. Antibiotics 11 (3), 421. https://doi.org/10.3390/antibiotics11030421 (2022).

    Google Scholar 

  12. Terreni, M., Taccani, M. & Pregnolato, M. New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives. Molecules 26 (9), 2671. https://doi.org/10.3390/molecules26092671 (2021).

    Google Scholar 

  13. Rhodes, A. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 43, 304–377. https://doi.org/10.1007/s00134-017-4683-6 (2017).

    Google Scholar 

  14. Gao, W. et al. Bacteriological analysis based on disease severity and clinical characteristics in patients with deep neck space abscess. BMC Infect. Dis. 22 (1), 280. https://doi.org/10.1186/s12879-022-07259-9 (2022).

    Google Scholar 

  15. Liu, Y. et al. The revitalization of antimicrobial peptides in the resistance era. Pharmacol. Res. 163, 105276. https://doi.org/10.1016/j.phrs.2020.105276 (2021).

    Google Scholar 

  16. Arulmozhi, P., Vijayakumar, S. & Kumar, T. Phytochemical analysis and antimicrobial activity of some medicinal plants against selected pathogenic microorganisms. Microb. pathogen. 123 https://doi.org/10.1016/j.micpath.2018.07.009 (2018). 219 – 26.

  17. Bricheux, A. et al. Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study. Clin. Microbiol. Inf. 25 (3), 383–e1. https://doi.org/10.1016/j.cmi.2018.11.020 (2019).

    Google Scholar 

  18. Salmon-Rousseau, A. et al. Comparative review of imipenem/cilastatin versus meropenem. Méd. Mal. Infect. 50 (4). https://doi.org/10.1016/j.medmal.2020.01.001 (2020). 316 – 22.

  19. Huo, X. et al. Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs). Acta Pharm. Sinica B. 9 (5), 986–996. https://doi.org/10.1016/j.apsb.2019.02.005 (2019).

    Google Scholar 

  20. Scharf, C. et al. Therapeutic drug monitoring of meropenem and piperacillin in critical illness—experience and recommendations from one year in routine clinical practice. Antibiotics 9 (3), 131. https://doi.org/10.3390/antibiotics9030131 (2020).

    Google Scholar 

  21. Mir, M. A., Mehraj, U. & Sheikh, B. A. Recent advances in chemotherapeutic implications of deguelin: a plant-derived retinoid. Nat. Prod. J. 11 (2), 169–181. https://doi.org/10.2174/2210315510666200128125950 (2021).

    Google Scholar 

  22. Wasana, K. G., Attanayake, A. P., Weerarathna, T. P. & Jayatilaka, K. A. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A doubleblind randomized placebo controlled clinical trial. Phytomedicine 81, 153431 (2021).

    Google Scholar 

  23. Dhiva, S., Bindu, R. & Vijay, V. K. A study on medicinal properties of Coccinia grandis. J. Transdisciplinary Env Technovation. 15, 8–12 (2021).

    Google Scholar 

  24. Rathinavel, T., Ammashi, S. & Shanmugam, G. Analgesic and anti-inflammatory potential of Lupeol isolated from Indian traditional medicinal plant Crateva adansonii screened through in vivo and in silico approaches. J. Genetic Eng. Biotechnol. 19 (1), 62 (2021).

    Google Scholar 

  25. Ribeiro, V. P., Arruda, C., Abd El-Salam, M. & Bastos, J. K. Brazilian medicinal plants with corroborated anti-inflammatory activities: a review. Pharm. biol. 56 (1), 253–268 (2018).

    Google Scholar 

  26. Díaz, K., Espinoza, L., Madrid, A., Pizarro, L. & Chamy, R. Isolation and identification of compounds from bioactive extracts of Taraxacum officinale Weber ex FH Wigg.(Dandelion) as a potential source of antibacterial agents. Evidence-based Comp. Alt Med, 2706417 (2018). (2018).

  27. Sakava, P. et al. Chemical constituents and antibacterial activities of Cameroonian dark brown propolis against potential biofilm-forming bacteria. Nat. Prod. Res. 2, 1–4 (2024).

    Google Scholar 

  28. Shaker, B., Ahmad, S., Lee, J., Jung, C. & Na, D. In silico methods and tools for drug discovery. Comput. biol. med. 137, 104851. https://doi.org/10.1016/j.compbiomed.2021.104851 (2021).

    Google Scholar 

  29. Jabalia, N., Kumar, A., Kumar, V. & Rani, R. In silico approach in drug design and drug discovery: an update. Inn Implement. Comp. Aided Drug Discov Strat Rat. Drug Des. 245. https://doi.org/10.1007/978-981-15-8936-2_10 (2021).

  30. Medugu, N. et al. Phenotypic and molecular characterization of beta-lactam resistant Multidrug-resistant Enterobacterales isolated from patients attending six hospitals in Northern Nigeria. Sci. rep. 13 (1), 10306. https://doi.org/10.1038/s41598-023-37621-z (2023).

    Google Scholar 

  31. Luan, C. W. et al. The pathogenic bacteria of deep neck infection in patients with type 1 diabetes, type 2 diabetes, and without diabetes from Chang Gung Research Database. Microorganisms 9 (10), 2059. https://doi.org/10.3390/microorganisms9102059 (2021).

    Google Scholar 

  32. Jayagandhi, S., Cheruvu, S. C., Manimaran, V. & Mohanty, S. Deep neck space infection: study of 52 cases. Ind. J. Otolaryngol. Head Neck Surg. 71 (Suppl 1), 923–926 (2019).

    Google Scholar 

  33. McHardy, J. A. et al. A case of neck abscess caused by rare hypervirulent Klebsiella pneumoniae, capsular type K20 and sequence type 420. Ann. Clin. Microbiol. Antimicrob. 20, 1–4. https://doi.org/10.1186/s12941-021-00453-8 (2021).

    Google Scholar 

  34. Russo, T. A. & Marr, C. M. Hypervirulent klebsiella pneumoniae. Clin. microbiol. reviews. 32 (3), 10–128 (2019).

    Google Scholar 

  35. Wei, J. et al. Antibiotic resistance of Klebsiella pneumoniae through β-arrestin recruitment-induced β-lactamase signaling pathway. Experim Th. med. 15 (3), 2247–2254. https://doi.org/10.3892/etm.2018.5728 (2018).

    Google Scholar 

  36. Song, L. et al. Application of GC/MS-based metabonomic profiling in studying the therapeutic effects of Huangbai–Zhimu herb-pair (HZ) extract on streptozotocin-induced type 2 diabetes in mice. JChromatography B. 997, 96–104. https://doi.org/10.1016/j.jchromb.2015.05.003 (2015).

    Google Scholar 

  37. Gurnani, N., Gupta, M., Mehta, D. & Mehta, B. K. Chemical composition, total phenolic and flavonoid contents, and in vitro antimicrobial and antioxidant activities of crude extracts from red chilli seeds (Capsicum frutescens L). J. Taibah Univ. Sci. 10 (4), 462–470. https://doi.org/10.1016/j.jtusci.2015.06.011 (2016).

    Google Scholar 

  38. Kumar, A. et al. Major phytochemicals: recent advances in health benefits and extraction method. Molecules 28 (2), 887. https://doi.org/10.3390/molecules28020887 (2023).

    Google Scholar 

  39. Deokar, G. S., Nagare, S. N., Deore, P. A., Kshirsagar, S. J. & Ahirrao, S. P. Coccinia grandis fruit extract gel for the treatment of mouth ulcer along with associated wound and inflammation. J. Res. Edu Ind. Med. 23, 43–58. https://doi.org/10.5455/JREIM.82-1457672904 (2017).

    Google Scholar 

  40. Hossain, S. A., Uddin, S. N., Salim, M. A. & Haque, R. Phytochemical and pharmacological screening of Coccinia grandis Linn. J. Sci. Inn Res. 3 (1), 65–71. https://doi.org/10.31254/jsir.2014.3111 (2014).

    Google Scholar 

  41. Waisundara, V. Y., Watawana, M. I. & Jayawardena, N. Costus speciosus and Coccinia grandis: Traditional medicinal remedies for diabetes. South. AfrJ Bot. 98, 1–5. https://doi.org/10.1016/j.sajb.2015.01.012 (2015).

    Google Scholar 

  42. Ahamed, A. et al. Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment. J. Cell. Biochem. 125 (2), e30515. https://doi.org/10.1002/jcb.30515 (2024).

    Google Scholar 

  43. Akash, S. et al. Novel computational and drug design strategies for inhibition of monkeypox virus and Babesia microti: molecular docking, molecular dynamic simulation and drug design approach by natural compounds. Front. Microbiol. 14, 1206816. https://doi.org/10.3389/fmicb.2023.1206816 (2023).

    Google Scholar 

  44. Arnittali, M., Rissanou, A. N. & Harmandaris, V. Structure of biomolecules through molecular dynamics simulations. Procedia Comput. Sci. 156, 69–78. https://doi.org/10.1016/j.procs.2019.08.181 (2019).

    Google Scholar 

  45. Mir, S. A., Meher, R. K. & Nayak, B. Molecular modeling and simulations of some antiviral drugs, benzylisoquinoline alkaloid, and coumarin molecules to investigate the effects on Mpro main viral protease inhibition. Biochem. Biophys. Rep. 34, 101459. https://doi.org/10.1016/j.bbrep.2023.101459 (2023).

    Google Scholar 

  46. Mir, S. A. et al. An exploration of binding of Hesperidin, Rutin, and Thymoquinone to acetylcholinesterase enzyme using multi-level computational approaches. J. Biomol. Struct. Dynamics. 42 (21), 11901–11915. https://doi.org/10.1080/07391102.2023.2265492 (2024).

    Google Scholar 

  47. Aier, I., Varadwaj, P. K. & Raj, U. Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Sci. rep. 6 (1). https://doi.org/10.1038/srep34984 (2016).

  48. Shkurti, A. et al. A PCA-based toolkit for compression and analysis of molecular simulation data. SoftwareX 5, 44–50. https://doi.org/10.1016/j.softx.2016.04.002 (2016).

    Google Scholar 

  49. Muthulakshmi, G. & Neelanarayanan, P. Antibacterial and Antifungal Activity of Coccinia grandis Leaves’ Extracts against Fish Pathogens. Asian J. Biolog Life Sci. 9 (3). https://doi.org/10.5530/ajbls.2020.9.65 (2020).

  50. Alshahrani, M. Y. et al. Inhibition realization of multidrug resistant bacterial and fungal isolates using Coccinia indica extracts. Saudi J. Biolog Sci. 29 (5), 3207–3212. https://doi.org/10.1016/j.sjbs.2022.01.045 (2022).

    Google Scholar 

  51. Ali, J. S., Riaz, N., Mannan, A., Tabassum, S. & Zia, M. Antioxidative-, antimicrobial-, enzyme inhibition-, and cytotoxicity-based fractionation and isolation of active components from Monotheca buxifolia (Falc.) A. DC. stem extracts. ACS omega. 7 (4), 3407–3423. https://doi.org/10.5614/crbb.2021.2.2/BOFY6724 (2022).

    Google Scholar 

  52. Muktar, B., Bello, I. A. & Sallau, M. S. Isolation, characterization and antimicrobial study of Lupeol acetate from the root bark of Fig-Mulberry Sycamore (Ficus sycomorus LINN). J. App Sci. Env Manag. 22 (7), 1129–1133. https://doi.org/10.4314/jasem.v22i7.21 (2018).

    Google Scholar 

  53. Chen, H. et al. Epidemiology and resistance mechanisms to imipenem in Klebsiella pneumoniae: A multicenter study. Mol. Med. Rep. 7 (1), 21–25. https://doi.org/10.3892/mmr.2012.1155 (2013).

    Google Scholar 

  54. Ezeh, P. A., Olayinka, B. O., Bolaji, R. O., Babangida, S. A. & Olowo-Okere, A. Phenotypic antibiotic susceptibility profile of clinical Enterobacteriaceae isolates from Kaduna State, northwest Nigeria. Access. Microbiol. 6 (6), 000747–v5. https://doi.org/10.1099/acmi.0.000747.v3 (2024).

    Google Scholar 

  55. Sallau, M. S. Isolation, characterization and antimicrobial study of Lupeol acetate from the root bark of Fig-Mulberry Sycamore (Ficus sycomorus LINN). JApp Sci. Env Manag. 22 (7), 1129–1133. https://doi.org/10.4314/jasem.v22i7.21 (2018).

    Google Scholar 

  56. Ekalu, A., Ayo, R. G., Habila, J. & Hamisu, İ. Bioactivity of phaeophytin A, α-amyrin and Lupeol from Brachystelma togoense Schltr. J. Turkish ChemSociety Sec A: Chem. 6 (3), 411–418. https://doi.org/10.18596/jotcsa.571770 (2019).

    Google Scholar 

  57. Wang, T. et al. Recent research and development of NDM-1 inhibitors. Eur. J. Med. Chem. 223 https://doi.org/10.1016/j.ejmech.2021.113667 (2021).

  58. Liu, K. et al. Lupeol and its derivatives as anticancer and anti-inflammatory agents: Molecular mechanisms and therapeutic efficacy. Pharmacol. res. 164, 105373. https://doi.org/10.1016/j.phrs.2020.105373 (2021).

    Google Scholar 

  59. Pereira, Beserra, F. et al. Lupeol, a pentacyclic triterpene, promotes migration, wound closure, and contractile effect in vitro: Possible involvement of PI3K/Akt and p38/ERK/MAPK pathways. Molecules 3023 (11), 2819 (2018).

    Google Scholar 

  60. Saha, S. et al. Lupeol Counteracts the Proinflammatory Signalling Triggered in Macrophages by 7-Keto‐Cholesterol: New Perspectives in the Therapy of Atherosclerosis. Oxid MedCell Longev. 1232816. (2020). https://doi.org/10.1155/2020/1232816 (2020).

  61. Musa, N. M., Sallau, M. S., Oyewale, A. O. & Ali, T. Antimicrobial activity of Lupeol and β-amyrin (triterpenoids) isolated from the rhizome of Dolichos pachyrhizus harm. Adv. J. Chem. A. 7 (1), 1–4. https://doi.org/10.48309/ajca.2024.387131.1380 (2024).

    Google Scholar 

  62. Javed, S. et al. Lupeol acetate as a potent antifungal compound against opportunistic human and phytopathogenic mold Macrophomina phaseolina. Sci. Rep. 11 (1), 8417. https://doi.org/10.1038/s41598-021-87725-7 (2021).

    Google Scholar 

  63. Min, T. R. et al. Suppression of EGFR/STAT3 activity by Lupeol contributes to the induction of the apoptosis of human non-small cell lung cancer cells. Int. J. oncol. 55 (1), 320–330 (2019).

    Google Scholar 

  64. Rathinavel, T., Ammashi, S. & Shanmugam, G. Analgesic and anti-inflammatory potential of Lupeol isolated from Indian traditional medicinal plant Crateva adansonii screened through in vivo and in silico approaches. J. Genetic EngBiotechnol. 19 (1). https://doi.org/10.1186/s43141-021-00167-6 (2021).

  65. Lenka, S. et al. Molecular characterization of head and neck infection causing bacterial communities using 16S rRNA in eastern Indian population. Gene Rep. 36, 101959. https://doi.org/10.1016/j.genrep.2024.101959 (2024).

    Google Scholar 

  66. Cherkaoui, A., Emonet, S., Renzi, G. & Schrenzel, J. Characteristics of multidrug-resistant Acinetobacter baumannii strains isolated in Geneva during colonization or infection. Ann. clin. microbiol. antimicrob. 14, 1–7. https://doi.org/10.1186/s12941-015-0103-3 (2015).

    Google Scholar 

  67. Lowings, M., Ehlers, M. M., Dreyer, A. W. & Kock, M. M. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa–an update. BMC infect. dis. 15, 1–0. https://doi.org/10.1186/s12879-015-1246-8 (2015).

    Google Scholar 

  68. Nguyen, A. T. et al. Overexpression of blaOXA-58 gene driven by ISAba3 is associated with imipenem resistance in a clinical Acinetobacter baumannii isolate from Vietnam. BioMed. Res. Int. 2020 (7213429). https://doi.org/10.1155/2020/7213429 (2020).

  69. Hanwell, M. D. et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. cheminformatics. 4, 1–7. https://doi.org/10.1186/1758-2946-4-17 (2012).

    Google Scholar 

  70. Sun, H. et al. Resensitizing carbapenem-and colistin-resistant bacteria to antibiotics using auranofin. Nat. communicat. 11 (1), 5263. https://doi.org/10.1038/s41467-020-18939-y (2020).

    Google Scholar 

  71. BIOVIA Discovery Studio Visualizer Software. Version 21.1.0.20298, Dassault Systèmes. (2021). https://www.3ds.com/products-services/biovia/products/molecular-modeling-simulation/biovia-discovery-studio/

  72. Meher, R. K. et al. Decoding dynamic interactions between EGFR-TKD and DAC through computational and experimental approaches: A novel breakthrough in lung melanoma treatment. J. Cell. Mol. Med. 28 (9), e18263. https://doi.org/10.1111/jcmm.18263 (2024).

    Google Scholar 

  73. Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. chem. 31 (2), 455–461. https://doi.org/10.1002/jcc.21334 (2010).

    Google Scholar 

  74. Pereira, G. R., Da Silva, A. N., Nascimento, D., De Mesquita, J. F. & S.S., & In silico analysis and molecular dynamics simulation of human superoxide dismutase 3 (SOD3) genetic variants. J. cell. biochem. 120 (3), 3583–3598. https://doi.org/10.1002/jcb.27636 (2019).

    Google Scholar 

  75. Sousa da Silva, A. W. & Vranken, W. F. ACPYPE-Antechamber python parser interface. BMC Res. Notes. 5, 1–8. https://doi.org/10.1186/1756-0500-5-367 (2012).

    Google Scholar 

  76. Kashefolgheta, S. & Verde, A. V. Developing force fields when experimental data is sparse: AMBER/GAFF-compatible parameters for inorganic and alkyl oxoanions. Phys. Chem. Chem. Phy. 19 (31), 20593–20607. https://doi.org/10.1039/C7CP02557B (2017).

    Google Scholar 

  77. Wang, J., Wang, W., Kollman, P. A. & Case, D. A. Automatic atom type and bond type perception in molecular mechanical calculations. J. mol. graph model. 25 (2), 247–260. https://doi.org/10.1016/j.jmgm.2005.12.005 (2006).

    Google Scholar 

  78. Lindorff-Larsen, K. et al. Improved side‐chain torsion potentials for the Amber ff99SB protein force field. Proteins: Struct. Funct. Bioinformat. 78 (8), 1950–1958. https://doi.org/10.1002/prot.22711 (2010).

    Google Scholar 

  79. Mark, P. & Nilsson, L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J. Phys. Chem. A. 105 (43), 9954–9960. https://doi.org/10.1021/jp003020w (2001).

    Google Scholar 

  80. Meher, R. K., Mir, S. A. & Anisetti, S. S. In silico and in vitro investigation of dual targeting Prima-1MET as precision therapeutic against lungs cancer. J. Biomol. Struct. Dynam. 42 (8), 4169–4184. https://doi.org/10.1080/07391102.2023.2219323 (2024).

    Google Scholar 

  81. Behera, B., Meher, R. K., Mir, S. A., Nayak, B. & Satapathy, K. B. Phytochemical profiling, in vitro analysis for anti-inflammatory, immunomodulatory activities, structural elucidation and in silico evaluation of potential selective COX-2 and TNF-α inhibitor from Hydrilla verticillata (Lf) Royle. J. Biomol. Struct. Dynam. 43 (2), 1–5. https://doi.org/10.1080/07391102.2023.2283871 (2023).

    Google Scholar 

  82. Borkotoky, S. & Murali, A. A computational assessment of pH-dependent differential interaction of T7 lysozyme with T7 RNA polymerase. BMC Struct. Biol. 17, 1–1. https://doi.org/10.1186/s12900-017-0077-9 (2018).

    Google Scholar 

  83. Hess, B., Bekker, H., Berendsen, H. J. & Fraaije, J. G. LINCS: a linear constraint solver for molecular simulations. J. Comput. chem. 18 (12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12%3C1463::AID-JCC4%3E3.0.CO;2-H (1997).

    Google Scholar 

  84. Mir, S. A. et al. Bioinspired thiazolo-[2, 3-b] quinazolin-6-one derivatives as potent anti-cancer agents targeting EGFR: their biological evaluations and in silico assessment. Mol. Div. 28 (4), 2479–2494. https://doi.org/10.1007/s11030-023-10688-6 (2024).

    Google Scholar 

  85. Mir, S. A. & Nayak, B. In silico analysis of binding stability of quercetin with CmpA and in vitro growth inhibition study of cyanobacterial species using Azadirachta indica extracts. Chem. Afr. 5 (3), 691–701. https://doi.org/10.1007/s42250-022-00335-2 (2022).

    Google Scholar 

  86. Ahamed, A. et al. Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment. J. Cell. Biochem. 125 (2), e30515. https://doi.org/10.1002/jcb.30515 (2024).

    Google Scholar 

  87. Mir, S. A. et al. synthesis, molecular modeling, and biological evaluations of novel chalcone based 4-Nitroacetophenone derivatives as potent anticancer agents targeting EGFR-TKD. J. Biomol. Struct. Dynam. 43 (8), 1–6. https://doi.org/10.1080/07391102.2024.2301746 (2024b).

    Google Scholar 

  88. Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 1, 19–25. https://doi.org/10.1016/j.softx.2015.06.001(2015).

  89. Kumari, R., Kumar, R., Lynn, A. & Open Source Drug Discovery Consortium. g_mmpbsa. A GROMACS tool for high-throughput MM-PBSA calculations. J. chem. Inf. model. 54 (7), 1951–1962. https://doi.org/10.1021/ci500020m (2014).

    Google Scholar 

  90. Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. mol. graph. 14 (1). https://doi.org/10.1016/0263-7855(96)00018-5 (1996). 33 – 8.

  91. Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. rep. 7, 42717. https://doi.org/10.1038/srep42717 (2017).

    Google Scholar 

  92. Pires, D. E., Blundell, T. L. & Ascher, D. B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. med. chem. 58, 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104 (2015).

    Google Scholar 

  93. Zahid, N. et al. In vitro and in silico validation of antibacterial potential of Pinus roxburghii and Cedrus deodara leaves’ extract against human pathogenic bacteria. J. King Saud University-Science. 35 (2), 102518. https://doi.org/10.1016/j.jksus.2022.102518 (2023).

    Google Scholar 

  94. Rehman, R. et al. Cystatin genes identification and antibacterial activity in medicinal plants used against clinical pathogens. SYLWAN 162, 62–90 (2018).

    Google Scholar 

  95. Lenka, S. et al. Implementation of Silver Nanoparticles Green Synthesized with Leaf Extract of Coccinia grandis as Antimicrobial Agents Against Head and Neck Infection MDR Pathogens. Curr. Pharmaceut Biotechnol. 25 (17), 2312–2325. https://doi.org/10.2174/0113892010290653240109053852 (2024).

    Google Scholar 

  96. Lv, H. et al. Discovery of isatin-β-methyldithiocarbazate derivatives as New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates. Biomed. Pharmacoth. 166, 115439. https://doi.org/10.1016/j.biopha.2023.115439 (2023).

    Google Scholar 

  97. Zhao, B. et al. Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates. Acta Pharm. Sinica B. 11, 203–221. https://doi.org/10.1016/j.apsb.2020.07.005 (2021).

    Google Scholar 

  98. Chang, C. D. et al. In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer. J. Enz Inhib. Med. Chem. 38, 2166039. https://doi.org/10.1080/14756366.2023.2166039 (2023).

    Google Scholar 

Download references